Accuray Incorporated (ARAY : NASDAQ)
Common Stock
$3.82
USD
+3.82 (3819900.00%)
Last updated: 2026-11-09
Stock Reverse Split
YesterdayThis stock executed a 1-for-40 reverse split on November 9, 2026. Historical prices have been adjusted accordingly.
Follow ARAY
ARAY
Accuray Incorporated
WealthAwesomePerformance
1 Day
+136328.57%
1 Week
+103143.24%
1 Month
+66917.54%
YTD
+44318.60%
Key Statistics
Market Cap
$11.46M
52W High
$4.05
52W Low
$0.00
P/E Ratio
-
50 Day MA
$0.21
200 Day MA
$0.35
Beta
1.38
Dividend Yield
-
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 11/9/2026 | $4.00 | $4.05 | $3.58 | $3.82 | $3.82 | 183,597 |
| 11/6/2026 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | 50,004 |
| 11/5/2026 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | 67,896 |
| 11/4/2026 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | 115,990 |
| 11/3/2026 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | 29,868 |
| 11/2/2026 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | 50,005 |
| 10/30/2026 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | 30,643 |
| 10/29/2026 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | 30,901 |
| 10/28/2026 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | 30,073 |
| 10/27/2026 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | 29,611 |
Analyst Price Targets
Based on analyst covering ARAY · as of Oct 5, 2026
Wall Street analysts forecast ARAY stock price to fall 90.8% over the next 12 months.
Consensus
BearishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
US$0.35
-90.8% Upside
Current Price
US$3.82
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on ARAY's historical volatility
30-Day Vol
2104.3%
Annualized
90-Day Vol
1221.5%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
US$4.57
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | US$4.05 | US$0.00 – US$5768.53 |
| 60 trading days | US$4.30 | US$0.00 – US$123878.05 |
| 90 trading days | US$4.57 | US$0.00 – US$1321399.48 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Accuray Incorporated
Accuray Incorporated engages in the design, development, and sale of radiosurgery and radiation therapy systems for the treatment of tumors throughout the body in the United States, Canada, Latin America, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. The company offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. It also provides the TomoTherapy platform, including the Radixact System, a tailored helical solution, which integrates radiation treatment planning, delivery, imaging, and data management; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, the company offers post-contract customer support, installation, training, and other professional services. It primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.
Financials
- Revenue (TTM)
- $401.95M
- EBITDA
- $-3.53M
- Profit Margin
- -12.24%
- ROE (TTM)
- -80.08%
- EPS (Diluted)
- -4.93
- Book Value
- 13.97
Classification
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Group
- Health Care Equipment & Services
🔄 Recent Splits
1-for-40
Nov 9, 2026
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Common Questions About ARAY.US
Market movers
Recent NASDAQ movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| STKH | Steakholder Foods Ltd | $2.83 | +404185.71% |
| ALPS | Alps Group Inc | $1.65 | +329900.00% |
| NXTS | Nexentis Technologies Inc. | $2.50 | +313025.00% |
| ZWZZT | NASDAQ TEST STOCK | $10.10 | +144185.71% |
| ADGM | Adagio Medical Holdings, Inc Common Stock | $1.92 | +87172.73% |
| OMH | Ohmyhome Limited Ordinary Shares | $25.84 | +251.09% |
| WCT | Wellchange Holdings Company Limited | $4.47 | +92.18% |
| SMX | SMX (Security Matters) Public Limited Company Class A Ordinary Shares | $9.35 | +89.73% |